Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?

To: Rob C. who wrote (13576)	5/19/1999 12:08:00 PM
From: David	Read Replies (1) \| Respond to of 26039

Rob, some years ago you would have had trouble selecting IDX from the crowd that included FINX, DBII, NRID, and AFIS. Since then we've seen the arrival of SACM, DDSI, and GDER. Probably I've left one out. The others are nowhere in bio-ID. In fact, I am having a hard time coming up with a credible competitor to IDX right now. As someone suggested to me, CTST was remarkable for its lack of competing products . . . because IDX's success is cutting off the wannabes' access to more venture capital. The difference has to be Fowler. IDX does not seem to have a genius lab guy coming up with breakthrough products every year. Fowler has just had a better sense of where to go with this company than any of his rivals, and if he missing a piece, he buys it with stock. If you are bullish on IDX, it's because Fowler has put the company in this favorable position. It might make you feel better if you realize that Scullion has been promoted, IDT retains a great deal of autonomy under prior management, and IDX has just recruited a new VP from RSI. Is it personal between you and Fowler?